Challenges in Positioning and Penetration of a New Medicine in the Minds of The Physicians: An Opinion Survey of Medical Representatives
DOI:
https://doi.org/10.61841/hg30vf56Keywords:
New Medicine, Medical Representatives, Physician Awareness, Access, Marketing Strategies.Abstract
This study examines the challenges faced by medical representatives in positioning and penetrating a new medicine in the minds of physicians. A survey of medical representatives was conducted to explore the key challenges, which include competition from established brands, limited time with physicians, lack of physician awareness, and limited access to physicians. These challenges can hinder the successful introduction of new medicines in the market. Therefore, it is essential for pharmaceutical companies to develop effective marketing strategies to overcome these obstacles. The findings of this study can inform the development of such strategies, which can lead to successful positioning and p
Downloads
References
• Al-Bakri, M. G., & Al-Azzam, S. I. (2013). Physicians’ perception and their willingness to
prescribe generic drugs: a systematic review. Journal of primary care & community health,
4(4), 251-261.
• Alghanim, S. A., & Alhamoudi, A. M. (2016). Knowledge, attitude, and practice of the
Saudi population towards generic medications. Saudi medical journal, 37(7), 755-761.
• Anand, S. (2016). A study on factors influencing prescription behavior of physicians.
Indian Journal of Marketing, 46(11), 16-25.
• Cohen, J. P., & Felix, A. (2014). Is the pharmaceutical industry improving with respect to
drug safety? Journal of health economics, 35, 57-74.
• Datta, S. K., & Borah, M. (2018). Factors influencing the prescription of fixed dose
combinations in India: a multilevel analysis. BMC public health, 18(1), 694.
• Dickson, M., Gagnon, J. P., & Keyhani, R. (2007). Trends in the globalization of clinical
trials. Nature Reviews Drug Discovery, 6(8), 647-654.
• Erlen, J. A., Sereika, S. M., & Quinn, B. (2011). Patient safety in medication
administration: a closer look at the importance of communication. Journal of nursing care
quality, 26(1), 33-39.
• Fishbein, M., & Ajzen, I. (2010). Predicting and changing behavior: The reasoned action
approach. Psychology Press.
• Gellad, W. F., & Kesselheim, A. S. (2011). Accelerated approval and expensive drugs–a
challenging combination. New England Journal of Medicine, 364(3), 188-189.
• Lai, L. J., & Tan, M. C. (2016). Medical representatives and generic drug promotion in the
Malaysian private healthcare sector. Journal of Pharmaceutical Health Services Research,
7(2), 85-90.
• Matsoso, M. P., & Fryatt, R. (2017). National drug policies and access to medicines in
developing countries. WHO South-East Asia Journal of Public Health, 6(1), 4-10.
• Mayet, A. Y., & Almehaid, M. A. (2017). Physicians' Perception and their Prescribing
Habits of Generic Drugs in Riyadh City, Saudi Arabia. International Journal of
Pharmaceutical Sciences and Research, 8(11), 4798-4806.
• Melander, H. (2011). Globalization and clinical trials: ethical concerns. Indian Journal of
Medical Ethics, 8(3), 188-189.
• Ratanawijitrasin, S. (2006). National drug policies: progress and challenges. Bulletin of the
World Health Organization, 84, 279-284.
• World Health Organization. (2000). The world health report 2000: health systems:
improving performance. Geneva: World Health Organization.
Published
Issue
Section
License
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
